• SENSEX 81,811.84
    -596.33 (--0.72%)
  • BANKNIFTY 56,252.85
    675.40 (+1.22%)
  • Dixon Technolog.
    14,550.00 19,149.80(%)
  • Kerala Ayurveda
    511.70 515.00(%)
  • Mazagon Dock
    3,358.00 3,778.00(%)
  • Garden Reach Sh.
    3,450.00 3,528.00(%)
  • Bank of Maha
    53.01 38.11(%)
  • Ola Electric
    43.20 45.06(%)
  • Zee Entertainmen
    146.80 163.90(%)
  • Bharat Electron
    420.50 410.00(%)
  • Cochin Shipyard
    2,244.00 2,977.10(%)
  • Trent
    6,105.30 8,345.85(%)
  • Waaree Energies
    2,927.75 1,808.65(%)
  • Apollo Micro Sys
    214.50 211.60(%)
  • Paras Defence
    1,739.85 1,943.60(%)
  • Aeroflex
    212.20 271.60(%)
  • Northern ARC
    235.80 351.00(%)
  • Zen Technologies
    1,995.30 2,627.95(%)
  • TCS
    3,370.10 3,060.25(%)
  • Multi Comm. Exc.
    8,247.20 8,108.35(%)
  • Swiggy
    394.40 617.00(%)
  • Suzlon Energy
    62.10 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kilitch Drugs (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3630.0
  • ISIN : INE729D01010
431.50 -9 (-2.10%)
  • As on 23 Jun 2025 (EOD)

  • Today’s Low

    422.75

  • Today’s High

    450.00

  • Open

    440.00

  • Perv Close

    440.75

  • 52W Low

    299.95

  • 52W High

    499.00

Key Indicators

  • P/E(TTM)

    22.72

  • Mar.Cap (₹Cr.)

    693.95

  • Div & Yield %

    0.00

  • Book Value(₹)

    157.28

  • Debt-Equity Ratio

    -2.10

  • AGM Date

    20-Jun-2025

  • EPS

    19.37

  • P/E Ratio

    22.72

Financials Ratios

  • Debt-Equity Ratio

    0.16

  • Mar.Cap (₹Cr.)

    693.95

  • RONW (%)

    8.28

  • ROCE (%)

    13.30

Score Board

  • Equity (₹ in Cr.)

    16.08

  • BV (₹)

    157.30

  • Sales( ₹ in Cr.)

    181.59

  • NP (in Cr.)

    31.16

  • NP Var(%)

    86.0

  • Div%

    0.0

  • CPS (₹)

    20.50

  • EPS (₹)

    19.40

  • Traded Value (₹ in Lakhs)

    707.62

  • 52 Week High

    499.00

  • 52 Week Low

    299.95

  • Price BSE

    440.0

  • Price NSE

    432.00

  • Market Capital( in Cr.)

    707.62

  • P/C Ratio

    21.50

  • P/E Ratio

    22.70

  • Price Vs.BV

    19.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 131.60 117.78 105.16 70.02 60.77 96.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 131.60 117.78 105.16 70.02 60.77 96.42
Other Income 6.19 4.60 4.56 4.19 5.71 4.52
Stock Adjustments 0.12 -0.23 0.05 -1.09 0.73 0.18
Total Income 137.91 122.15 109.77 73.12 67.21 101.12
EXPENDITURE :            
Raw Materials 66.33 58.27 60.29 37.97 36.49 53.16
Power and Fuel Cost 2.36 2.15 2.00 1.57 1.62 1.41
Employee Cost 7.91 7.47 6.15 5.22 5.65 5.23
Other Manufacturing Expenses 4.69 5.37 5.91 5.48 4.62 3.80
Selling and Administration Expenses 26.71 23.08 16.48 11.11 11.12 12.13
Miscellaneous Expenses 3.29 3.88 3.25 2.25 0.40 4.00
Employee Benefit Expenses 7.91 7.47 6.15 5.22 5.65 5.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.29 100.22 94.08 63.59 59.91 79.74
Operating Profit 26.62 21.94 15.69 9.53 7.31 21.38
Interest 2.02 1.15 0.80 0.88 0.93 0.65
Gross Profit 24.60 20.79 14.89 8.65 6.38 20.73
Depreciation 1.24 1.34 0.96 1.14 1.15 1.20
Profit Before Tax 23.36 19.45 13.93 7.51 5.23 19.53
Current Tax 6.37 4.20 3.63 1.67 0.70 4.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.59 -0.47 -0.23 -0.31 0.07 0.52
Reported Net Profit 17.57 15.72 10.53 6.16 4.46 14.77
Extraordinary Items 0.86 0.77 1.00 0.94 1.55 1.72
Adjusted Net Profit 16.71 14.95 9.53 5.22 2.91 13.05
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 113.96 98.24 87.71 81.56 78.03 64.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.93 0.93
P & L Balance carried down 131.53 113.96 98.24 87.71 81.56 78.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 10.93 10.09 6.76 3.97 2.89 9.62
Earnings Per Share(Adj)-Unit Curr 10.93 10.09 6.76 3.97 2.89 9.62
Book Value 138.61 122.53 112.65 105.16 98.25 98.39
Book Value(Adj)-Unit Curr 138.61 122.53 112.65 105.16 98.25 98.39

Shareholding Pattern

  • Promoter Group

    69.23%

  • Public Share Holding

    30.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 6,629,342 41.22 6,629,342 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,504,831 28.01 4,504,831 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,134,173 69.23 11,134,173 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100 0.00 100 1
2] Non Institution
Bodies Corporate 275,854 1.72 274,754 54
Clearing Members 470 0.00 470 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 200 0.00 0 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 162,510 1.01 162,510 132
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 154,799 0.96 154,799 238
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,545,501 9.61 1,545,501 19
Individuals holding nominal share capital up to Rs. 1 lakh 2,566,974 15.96 2,212,002 9,293
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 232,916 1.45 232,916 1
Sub Total 4,948,046 30.77 4,591,774 9,744
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,082,319 100.00 15,726,047 9,749

Company Background

Kilitch Drugs (India) LtdPharmaceuticals - Indian - Formulations

  • Kilitch Drugs (India) Ltd
  • BSE Code : 3630.0
  • ISIN : INE729D01010

  • Incorporation Year

    1992

  • Registered Office

    C-301/2 MIDC TTC Indl Area
    Pawane Village, Thane,
    Maharashtra-400705

  • Telephone

    91-022-27670322/27680913/65144185

  • FAX

    91-022-27680912

  • Chairman

    Mukund P Mehta

  • Managing Director

    Mukund P Mehta

  • Company Secretary

    Pushpa Nyoupane

  • Auditor

    Suryaprakash Maurya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Kilitch Drugs (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kilitch Drugs 440.00 137.79 131.60 22.72 10.74
Abbott India 31,529.10 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,883.00 1,330.33 1,295.53 191.86 33.26
P & G Health Ltd 5,891.05 1,166.89 1,151.26 38.93 39.76
Glaxosmi. Pharma 3,205.20 3,866.05 3,723.49 59.08 58.72
Cipla 1,500.50 17,645.00 16,574.34 23.50 20.10
Amrutanjan Healt 724.00 437.58 421.23 41.18 20.84
Guj. Themis Bio. 321.05 174.19 169.82 71.66 44.82
Fermenta Biotec. 315.30 315.24 307.09 13.73 4.10
Bliss GVS Pharma 138.25 638.96 605.46 21.11 11.19
Ambalal Sarabhai 35.59 11.70 3.81 32.95 1.92